IAP-086-1: A Phase 1 Single Ascending Dose First-Time in Human Study

Abroad (travel likely)RecruitingPHASE1

Conditions

HIV-1-infection

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University of North Carolina, Chapel Hill, North Carolina, United States
Contact: Study coordinator (Susan Pedersen) · susan_pedersen@med.unc.edu · 919-966-6713
Contact: Principal Investigator (Cynthia Gay, MD)

Study leads

Cynthia Gay, MD
Principal Investigator
UNC Chapel Hill

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

PET Imaging of Radiolabeled Anti-HIV-1 Envelope Monoclonal Antibody (VRC01)

HIV-1-infection

Abroad (travel likely)RecruitingPHASE1

San Francisco, United States

Leukapheresis Procedures to Obtain Plasma and Lymphocytes for Research Studies on Antiretroviral Naive HIV-1 Research Participants

HIV

Abroad (travel likely)Recruiting

Bethesda, United States

Imaging and Biopsy of People With HIV-1 Undergoing Analytic Treatment Interruption

HIV

Abroad (travel likely)RecruitingPHASE2

Bethesda, United States

A Study of GS-3242 in Combination With Lenacapavir Versus Biktarvy in Virologically Suppressed People With HIV-1

HIV-1-infection

Abroad (travel likely)RecruitingPHASE2

Ft. Pierce, United States · Dallas, United States